Recurrent Abortion Clinical Trial
Official title:
Sildenafil Citrate for Treatment of Unexplained Recurrent Spontaneous Abortion
Two groups of unexplained recurrent spontaneous abortion, each included 65 participants.
scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The
intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and
continued till the 12th-week of gestation.
The primary outcome measure was the difference in the live birth between both groups.
Secondary outcome measures were the differences between both groups regard pulsatility index
(PI) and resistance index (RI), a number of take-home babies, the reported side-effects of
treatment and the pregnancy-related complications.
Two groups of unexplained recurrent spontaneous abortion, each included 65 participants.
scheduled randomly into; the study group received Sildenafil Citrate and Placebo group. The
intervention started from day 21-23 of the cycle preceding spontaneous pregnancy and
continued till the 12th-week of gestation.
The primary outcome measure was the difference in the live birth between both groups.
Secondary outcome measures were the differences between both groups regard PI and RI, a
number of take-home babies, the reported side-effects of treatment and the pregnancy-related
complications, e.g., preeclampsia and intrauterine growth restriction (|IUGR).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02088424 -
the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION
|
N/A | |
| Completed |
NCT01612065 -
Optimum Misoprostol Dose Prior to Office Hysteroscopy
|
Phase 3 | |
| Completed |
NCT01051778 -
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
|
Phase 2 | |
| Completed |
NCT02457377 -
Laparoscopic Transabdominal Cerclage: New Approach
|
N/A | |
| Not yet recruiting |
NCT04326595 -
Histopathological Evaluation of Product of Conception in Sporadic and Recurrent Abortions
|
N/A | |
| Completed |
NCT01976676 -
Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion
|
Phase 2/Phase 3 |